---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-167330"
form_type: "8-K"
ticker: "CALC"
cik: "0001534133"
company_name: "CalciMedica, Inc."
filed_at: "2023-06-15T23:59:59+00:00"
generated_at: "2026-06-14T00:08:08.774645+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# CalciMedica posts updated corporate presentation; no specific new data disclosed in filing

## Summary
- Company posted an updated corporate presentation on the 'Investors and Media' section of its website.
- Presentation titled 'Developing First-in-Class Therapies for Acute Inflammatory Diseases with High Unmet Need' is dated June 2023.
- No financial results, pipeline milestones, or other quantifiable updates are provided in the attached exhibit.
- Presentation may be used in discussions with analysts and investors; content is furnished, not filed.

## SEC filing metadata
- accession: 0001193125-23-167330
- form_type: 8-K
- ticker: CALC
- cik: 0001534133
- company_name: CalciMedica, Inc.
- filed_at: 2023-06-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534133/000119312523167330/0001193125-23-167330-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534133/000119312523167330/d474125d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-167330
- JSON: https://secwatch.observer/filing/0001193125-23-167330.json
- Plain text: https://secwatch.observer/filing/0001193125-23-167330.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.